This provided the rationale for engineering rhCD137L-MSNs which bind to CD137 on NPC cells and neutralize it, thus converting the immune-suppressive axis to a T cell-stimulatory signal. Here, TNFRSF9 is linked to nasopharyngeal carcinoma.